Fusion Antibodies 주식 가격. FAB - 주식 시세, 차트, 과거 거래, 주식 채팅, 재무.

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

프리미엄

가격

8.75

매수가

8.50

매도가

9.00

거래량

476,316

8.60 일간 변동폭 9.00

2.90 52주 범위 11.75

market_cap

8.344M

전일 종가

9.00

개장가

9.00

최근 거래 시간

8.725

(O)

마지막 거래 시간

재정 규모

VWAP

평균 볼륨(3m)

1,614,563

발행 주식

95,365,564

배당수익률

주가수익률

-3.76

주당순이익(EPS)

-0.02

매출

1.14M

순이익

-2.23M

섹터

Pharmaceutical Preparations

산업

Pharmaceutical Preparations

웹사이트

www.fusionantibodies.com

본부

Belfast, Gbr

설립됨

Fusion Antibodies Plc is listed in the Pharmaceutical Preparations sector of the 런던증권거래소 with ticker FAB. The last closing price for Fusion Antibodies was 9p. Over the last year, Fusion Antibodies shares have traded in a share price range of 2.90p to 11.75p.

Fusion Antibodies currently has 95,365,564 shares in issue. The market capitalisation of Fusion Antibodies is £8.58 million. Fusion Antibodies has a price to earnings ratio (PE ratio) of -3.76.

Fusion Antibodies receives approval of grant funding application

Fusion Antibodies PLC on Wednesday announced the approval of a grant funding application to The Northern Ireland Prec ...

Fusion Antibodies PLC Approval of Grant Funding Application

Fusion Antibodies PLC 04 December 2024 The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse...

Fusion Antibodies interim loss narrows as revenue more than doubles

Fusion Antibodies PLC on Tuesday said its loss narrowed in the first half of its current financial year, as revenue m ...

Fusion Antibodies PLC Half-year Report

Fusion Antibodies PLC 19 November 2024 The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse...

Fusion Antibodies PLC Director/PDMR Shareholding

Fusion Antibodies PLC 16 October 2024 16 October 2024 Fusion Antibodies plc ("Fusion" or the "Company") Director/PDMR Shareholding Fusion Antibodies plc (AIM: FAB), specialists in...

Fusion Antibodies PLC Issue of shares to non-executive directors

Fusion Antibodies PLC 16 October 2024 The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse...

IN BRIEF: Fusion Antibodies expects interim revenue to double

PLC - Belfast-based contract researcher that provides discovery, design and optimisation services for therapeutic ant ...

Fusion Antibodies PLC Result of AGM

Fusion Antibodies PLC 08 October 2024 Fusion Antibodies plc ("Fusion" or the "Company") Result of AGM Fusion Antibodies plc (AIM: FAB), specialists in pre-clinical antibody discovery...

Fusion Antibodies PLC AGM statement and trading update

Fusion Antibodies PLC 08 October 2024 The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse...

Fusion Antibodies PLC Block admission six monthly return

Fusion Antibodies PLC 02 October 2024 2 October 2024 Fusion Antibodies plc ("Fusion" or the "Company") Block admission six monthly return Fusion Antibodies plc (AIM: FAB), specialists...

Fusion Antibodies receives approval of grant funding application

Fusion Antibodies PLC on Wednesday announced the approval of a grant funding application to The Northern Ireland Prec ...

Fusion Antibodies PLC Approval of Grant Funding Application

Fusion Antibodies PLC 04 December 2024 The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse...

Fusion Antibodies interim loss narrows as revenue more than doubles

Fusion Antibodies PLC on Tuesday said its loss narrowed in the first half of its current financial year, as revenue m ...

Fusion Antibodies PLC Half-year Report

Fusion Antibodies PLC 19 November 2024 The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse...

Fusion Antibodies PLC Director/PDMR Shareholding

Fusion Antibodies PLC 16 October 2024 16 October 2024 Fusion Antibodies plc ("Fusion" or the "Company") Director/PDMR Shareholding Fusion Antibodies plc (AIM: FAB), specialists in...

Fusion Antibodies PLC Issue of shares to non-executive directors

Fusion Antibodies PLC 16 October 2024 The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse...

IN BRIEF: Fusion Antibodies expects interim revenue to double

PLC - Belfast-based contract researcher that provides discovery, design and optimisation services for therapeutic ant ...

Fusion Antibodies PLC Result of AGM

Fusion Antibodies PLC 08 October 2024 Fusion Antibodies plc ("Fusion" or the "Company") Result of AGM Fusion Antibodies plc (AIM: FAB), specialists in pre-clinical antibody discovery...

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	-0.4	-4.37158469945	9.15	9.55	8.05	1238204	8.89660301	DE
4	1.7	24.1134751773	7.05	11.75	7.05	1940593	9.19972822	DE
12	4.5	105.882352941	4.25	11.75	3.95	1614563	7.17980664	DE
26	5.35	157.352941176	3.4	11.75	2.9	1345387	5.72558325	DE
52	4	84.2105263158	4.75	11.75	2.9	1260318	4.81718866	DE
156	-87.25	-90.8854166667	96	107.5	2.9	761742	6.19606665	DE
260	-84.25	-90.5913978495	93	250	2.9	470422	10.78396443	DE

FAB - Frequently Asked Questions (FAQ)

What is the current Fusion Antibodies share price?

The current share price of Fusion Antibodies is 8.75p

How many Fusion Antibodies shares are in issue?

Fusion Antibodies has 95,365,564 shares in issue

What is the market cap of Fusion Antibodies?

The market capitalisation of Fusion Antibodies is GBP 8.58M

What is the 1 year trading range for Fusion Antibodies share price?

Fusion Antibodies has traded in the range of 2.90p to 11.75p during the past year

What is the PE ratio of Fusion Antibodies?

The price to earnings ratio of Fusion Antibodies is -3.76

What is the cash to sales ratio of Fusion Antibodies?

The cash to sales ratio of Fusion Antibodies is 7.35

What is the reporting currency for Fusion Antibodies?

Fusion Antibodies reports financial results in GBP

What is the latest annual turnover for Fusion Antibodies?

The latest annual turnover of Fusion Antibodies is GBP 1.14M

What is the latest annual profit for Fusion Antibodies?

The latest annual profit of Fusion Antibodies is GBP -2.23M

What is the registered address of Fusion Antibodies?

The registered address for Fusion Antibodies is 1 SPRINGBANK ROAD, SPRINGBANK INDUSTRIAL ESTATE, DUNMURRY, BELFAST, BT17 0QL

What is the Fusion Antibodies website address?

The website address for Fusion Antibodies is www.fusionantibodies.com

Which industry sector does Fusion Antibodies operate in?

Fusion Antibodies operates in the PHARMACEUTICAL PREPARATIONS sector

가장 활성
% 상승자
% 패자

기호	가격	볼륨
MACMarechale Capital Plc	3.80p (117.14%)	38.62M
DKEDukemount Capital Plc	0.045p (42.86%)	905.37M
SCGLSealand Capital Galaxy Limited	8.00p (37.93%)	13.92M
OBDOxford Biodynamics Plc	0.65p (30.00%)	5.03M
BKYBerkeley Energia Limited	19.25p (20.31%)	1.06M
NFXNuformix Plc	0.085p (-41.38%)	262.46M
PPSProton Motor Power Systems Plc	0.225p (-25.00%)	983.97k
VASTVast Resources Plc	0.115p (-19.30%)	183.07M
GSCGs Chain Plc	1.30p (-16.13%)	629k
SYMESupply@me Capital Plc	0.0026p (-16.13%)	144.24M
DKEDukemount Capital Plc	0.045p (42.86%)	905.37M
NTVONativo Resources Plc	0.0019p (0.00%)	467.88M
INSPInspirit Energy Holdings Plc	0.0029p (11.54%)	429.63M
MSMNMosman Oil And Gas Limited	0.025p (-3.85%)	401.42M
TRPTower Resources Plc	0.0285p (-3.39%)	303.27M